Q1 2025 Earnings Call Transcript May 13, 2025 Fennec Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.04 ...

Fennec Pharmaceuticals Inc (FENC) reports an 18% increase in net product sales, while navigating cash burn and operational expenses.

Fennec Pharmaceuticals Inc.’s FENC share price has surged by 6.81%, which has investors questioning if this is right time to sell.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Like wolves, coyotes and other foxes, the fennec fox is a member of the canid family. There are 11 members of the canid family that call Africa home. Weighing just 2 to 3.5 pounds when fully grown ...

RESEARCH TRIANGLE PARK, N.C., May 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the ...

Robert Andrade; Chief Financial Officer; Fennec Pharmaceuticals Inc. Jeffrey Hackman; Chief Executive Officer, Director; Fennec Pharmaceuticals Inc. Chase Knickerboc ...

Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ~ Positive Momentum from Company's Refined, Targeted Sales Strategy and Enhanced Patient Support Services ~ ...

Fennec Pharmaceuticals Inc. ( NASDAQ: FENC) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Officer and Director ...